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CASE REPORT
A forme fruste of Shone’s anomaly in a 65 year-old
patient
Sherif E Moustafa*, Jacques Lesperance, Jean-Lucien Rouleau, Gilbert
Gosselin
ABSTRACT: Shone’s anomaly, a congenital cardiac malformation complex, consists of multiple levels
of left heart obstruction. A rare case of an incomplete form of this anomaly discovered incidentally
during cardiac catheterization for an unrelated event is described.
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INTRODUCTION
In 1963, Shone et al. described a syndrome consisting
of multilevel obstruction of all left heart structures. The
original features of Shone’s complex include mitral
supra-annular ring, parachute mitral valve, subaortic
stenosis, and coarctation of the aorta (CoA) (1).
In clinical practice, the definition of Shone’s anomaly
has been extended beyond the original Shone complex,
to include patients with additional forms of left heart
anomalies, such as mitral and aortic valvular lesions and
supra-valvular aortic stenosis (SVAS). In the forme
fruste, or incomplete form, some of the obstructions are
present, whereas others are absent or only of minor
relevance. We describe a 65-year-old male patient
presenting with congestive heart failure (CHF). Cardiac
catheterization revealed a variant of Shone’s complex
during routine coronary angiography to rule out
atherosclerotic coronary artery disease (CAD).
CASE PRESENTATION
An active 65-year-old man was admitted to the
hospital service with CHF. History was remarkable for
CoA repair (at 11 years of age), sick sinus syndrome
with permanent pacemaker implantation 8 years ago,
diabetes mellitus and hypothyroidism. Twelve years
ago, he presented with CHF. He underwent
transthoracic echocardiogram (TTE) that revealed mild
apical and anterior wall segmental wall motion
abnormalities (SWMA) and normal global ejection
fraction (EF) of 50%. Coronary arteries were free from
significant atherosclerotic CAD at that time. He
remained symptom free on antifailure medications until
his recent hospitalization with severe CHF (III/IV
NYHA classification). Cardiovascular examination
revealed a systolic thrill over the base with a harsh 4/6
ejection systolic murmur best heard over the aortic
areas, as well as a soft 3/6 apical holosystolic murmur.
Jugular venous pressure was estimated at 18 mmHg.
ECG showed atrial fibrillation, pacemaker spikes and
left bundle branch block pattern. Laboratory data was
notable for raised troponin T 1.6 ng/mL (normal < 0.03
ng/mL) and creatine kinase-MB 51 ng/mL (normal <
6.2 ng/mL).
Coronary angiography did not demonstrate significant
atherosclerotic CAD. Selective left ventricle (LV)
angiography and aortography revealed mildly dilated
LV with severe systolic (EF = 15-20%) and diastolic
(restrictive pattern) dysfunction, severe endomyocardial
calcification (presumably secondary to fibroelastosis of
both ventricles), multiple segmental wall motion
abnormalities, severe subvalvular mitral calcification
with mild valvular mitral stenosis (MS) (estimated
mitral valve area = 2.0 cm2) and severe (3/4) mitral
regurgitation, bicuspid aortic valve (BAV) with
moderately severe valvular aortic stenosis (AS)
(estimated aortic valve area = 0.7 cm2), markedly
dilated right ventricle with severe pulmonary
hypertension (75/40/55 mmHg systolic/diastolic/mean
pressure), mild SVAS without a gradient (Figure 1) and
mild residual CoA without a gradient (Figure 2). TTE
confirmed the aforementioned findings. In addition, it
*To whom correspondence should be addressed:
Gilbert Gosselin
Montreal Heart Institute
5000 Belanger Street, Montreal, QC H1T 1C8, Canada
Email: gilbert.gosselin@icm-mhi.org20 McGill Journal of Medicine 2008
uncovered restricted calcified posterior papillary
muscle. Dobutamine stress echocardiogram was
negative for ischemia.
At that time, the suspected reason for CHF was
myocarditis and the patient was followed up closely
after hospital dismissal. Three months later, he returned
for evaluation for surgical correction. Repeated cardiac
catheterization revealed pulmonary vascular resistance
of 11.4 which reduced to 4.4 wood’s units (Normal
range = 0.7 – 1.1 wood’s units) with decreased
pulmonary pressure from 65/34/47 to 29/13/20 mmHg
(systolic/diastolic/mean pressure) after Nitroprusside
infusion. EF was 40-46% by TTE and Multiple Gated
Acquisition Scan (MUGA). Decision was made for
close follow up on antifailure measures including beta
blocker (Bisoprolol), acetylsalicylic acid, angiotensin
converting enzyme inhibitor (Perindopril) and
simvastatin. Surgical correction was declined due to
high risk and progressive improvement of EF. The
patient’s condition improved progressively with a stable
EF of 40-45% during follow up in the heart function
clinic. There were no major complications or
hospitalizations during the follow up period.
DISCUSSION
In this report, we described a case that can be regarded
as a forme fruste of Shone’s anomaly including
subvalvular mitral abnormalities, valvular mitral
stenosis, bicuspid aortic valve, valvular aortic stenosis,
supravalvular aortic stenosis and coarctation of the
aorta with the absence of the supra-annular mitral ring.
These anomalies tend to coexist, but the wide range of
severity and predominance of each individual lesion
may make optimal management troublesome. Even
though the incomplete form of this anomaly is prone to
be less symptomatic, it is nevertheless surprising that it
remained unnoticed in this patient until his mid-sixties.
On their own, moderately severe AS and MS can be
tolerated for a long time (2).
Our patient presented earlier in his life with CoA as
the predominant outflow obstructive lesion. CoA may
conceal the presence and potential hemodynamic
severity of associated intracardiac lesions (3).
Physicians were cautioned to be aware of other left-
sided obstructive lesions that could be present in the
symptomatic infant with CoA. The correlation of
obstructive left-sided anomalies associated with CoA
was confirmed by Becker et al. The authors believed
that Shone’s anomaly should be contemplated in those
patients who have ongoing signs of CHF after operative
repair of the CoA (4).
Shone et al. (1) noted that mitral valve obstruction
appeared to be the most critical problem associated with
the anomaly. Mitral commissurotomy alone was not
adequate to relieve the obstruction. Bolling et al.
confirmed the belief that severity of the mitral valve
obstruction correlates inversely with long-term outcome
and that operative mortality in patients with this
anomaly is negatively influenced by the extent of mitral
valve disease. The patients who demonstrated
substantially elevated pulmonary artery pressures were
those with the worst mitral obstruction and had, in
general, the poorest outcome (5). In our case, MS was
mild and this correlated well with the patient’s
longevity.
In conclusion, this rarely reported case of Shone’s
anomaly in an elderly patient draws attention to the
importance of performing a meticulous search for other
associated lesions in patients presenting early in life
with CoA or any form of left ventricular outflow tract
obstruction to prevent later presentation with end stage
heart failure or myocardial disease.
Figure 1: Left ventricular angiography in 1950 showing SVAS
(arrow) and akinesia of the whole apex.
Figure 2: Aortogram in 2004 showing residual CoA repair site
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